Changes in Vitamin D and Gut Microbiota in Pediatric Hematopoietic Stem Cell Transplantation Patients with Bloodstream Infections
International Journal for Vitamin and Nutrition Research · 2025
DOI: 10.31083/ijvnr26126 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal for Vitamin and Nutrition Research, 2025. Verfasst von Qian Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Aerospace Center Hospital, 100049 Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Hematopoietic Stem Cell Transplantation, Vitamin D, Bacteremia. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aerospace Center Hospital Youth Innovation Fund.
Abstract (Originalsprache)
Background
Vitamin D (VD) and gut microbiota (GM) are important variables in pediatric hematopoietic stem cell transplantation (HSCT) recipients with bloodstream infections (BSI). Both VD and GM play significant roles in immune regulation and in maintaining intestinal barrier function.
Methods
This prospective case-control study included 48 consecutive pediatric patients who underwent HSCT, as well as 20 healthy children from the community. Plasma samples were collected pre- and post-HSCT, together with post-HSCT fecal samples. Serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) were measured using chemiluminescence and enzyme linked immunosorbent assay, respectively. GM was analyzed by 16S rDNA next generation sequencing.
Results
The incidence of BSI in pediatric HSCT recipients was 33.3% (16/48). No significant differences in serum 25(OH)D or 1,25(OH)2D3 levels were observed between the BSI and non-BSI groups either before or after transplantation, or with the healthy control group. The α-diversity of GM in BSI and non-BSI patients was significantly lower than in healthy subjects. Proteobacteria were significantly more abundant in BSI patients than in non-BSI patients (p = 0.0434) or healthy controls (p = 0.0193). Pediatric HSCT patients showed significantly higher levels of Staphylococcus (p < 0.001), Pseudomonas (p < 0.001), Enterococcus (p < 0.001), Clostridium innocuum (p = 0.0175) and Enterobacter (p = 0.0394) compared to the controls, whereas the levels of Firmicutes (p = 0.009), Actinobacteria (p < 0.001), Bifidobacterium (p < 0.001) and Faecalibacterium (p < 0.001) were significantly lower. β-diversity analysis revealed significant population differences between the three groups.
Conclusions
These results indicate there is no practical value in monitoring VD in HSCT patients. During HSCT and BSI, the GM experiences a loss of probiotics and an increase in potential pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Aerospace Center Hospital, 100049 Beijing, China.
- Department of Hematology, Aerospace Center Hospital, 100049 Beijing, China.
Förderung
- Aerospace Center Hospital Youth Innovation Fund
Zitieren
APA
Gao, Q., Bai, M., Qi, T., Zhai, J., Song, Y., Zhang, W., & Liang, G. (2025). Changes in Vitamin D and Gut Microbiota in Pediatric Hematopoietic Stem Cell Transplantation Patients with Bloodstream Infections. International Journal for Vitamin and Nutrition Research. https://doi.org/10.31083/ijvnr26126
Vancouver
Gao Q, Bai M, Qi T, Zhai J, Song Y, Zhang W, et al. Changes in Vitamin D and Gut Microbiota in Pediatric Hematopoietic Stem Cell Transplantation Patients with Bloodstream Infections. International Journal for Vitamin and Nutrition Research. 2025. doi:10.31083/ijvnr26126
BibTeX
@article{Gao2025,
author = {Gao, Qian and Bai, Mingjian and Qi, Tianqi and Zhai, Jing and Song, Yan and Zhang, Weijie and Liang, Guowei},
title = {Changes in Vitamin D and Gut Microbiota in Pediatric Hematopoietic Stem Cell Transplantation Patients with Bloodstream Infections},
journal = {International Journal for Vitamin and Nutrition Research},
year = {2025},
doi = {10.31083/ijvnr26126}
}
EUVIMED